These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 12407777)

  • 1. Assessing the interaction of particulate delivery systems with lung surfactant.
    Wiedmann TS
    Methods Mol Med; 2003; 75():755-69. PubMed ID: 12407777
    [No Abstract]   [Full Text] [Related]  

  • 2. Can nanotechnology hit the spot in aerosol-based drug delivery for lung disorders?
    Joshi N
    Ther Deliv; 2018 Mar; 9(4):233-236. PubMed ID: 29495926
    [No Abstract]   [Full Text] [Related]  

  • 3. Delivery and performance of surfactant replacement therapies to treat pulmonary disorders.
    El-Gendy N; Kaviratna A; Berkland C; Dhar P
    Ther Deliv; 2013 Aug; 4(8):951-80. PubMed ID: 23919474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lavage administration of dilute surfactants after acute lung injury in neonatal piglets.
    Balaraman V; Meister J; Ku TL; Sood SL; Tam E; Killeen J; Uyehara CF; Egan E; Easa D
    Am J Respir Crit Care Med; 1998 Jul; 158(1):12-7. PubMed ID: 9655700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exogenous surfactant as a drug delivery agent.
    Haitsma JJ; Lachmann U; Lachmann B
    Adv Drug Deliv Rev; 2001 Apr; 47(2-3):197-207. PubMed ID: 11311992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic efficiency of early and late administration of surfactant-BL during bleomycin-induced damage to rat lungs.
    Volchkov VA; Dubrovskaya VF; Klestova OV; Val'kovich AA; Serzhanina VA; Seiliev AA; Rosenberg OA
    Bull Exp Biol Med; 2006 Jun; 141(6):682-4. PubMed ID: 17364048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surfactant therapy of pulmonary conditions excluding those with primary surfactant deficiency and bronchoscopy as delivery method: an overview of Russian patents and publications.
    Jargin SV
    Recent Pat Drug Deliv Formul; 2013 Aug; 7(2):134-7. PubMed ID: 23157179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of different surfactants on pulmonary group B streptococcal infection in premature rabbits.
    Sherman MP; Campbell LA; Merritt TA; Long WA; Gunkel JH; Curstedt T; Robertson B
    J Pediatr; 1994 Dec; 125(6 Pt 1):939-47. PubMed ID: 7996369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The wet bridge transfer system: a novel tool to assess exogenous surfactant as a vehicle for intrapulmonary drug delivery.
    Baer B; Veldhuizen EJA; Possmayer F; Yamashita C; Veldhuizen R
    Discov Med; 2018 Nov; 26(144):207-218. PubMed ID: 30695680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitigation of meconium-induced lung injury by surfactant and inhaled nitric oxide is associated with suppression of nuclear transcription factor kappa B.
    Hu X; Cao L; Lam LK; Zhu L; Guo C; Sun B
    Biol Neonate; 2005; 87(2):73-81. PubMed ID: 15692188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A theoretical study of chemical delivery within the lung using exogenous surfactant.
    Zhang YL; Matar OK; Craster RV
    Med Eng Phys; 2003 Mar; 25(2):115-32. PubMed ID: 12538066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exogenous surfactant in acute lung injury: no longer a question?
    Westphal M; Traber DL
    Crit Care Med; 2005 Oct; 33(10):2431-3. PubMed ID: 16215412
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of inhaled nitric oxide and surfactant treatment on lung function and pulmonary hemodynamics in bronchoalveolar-lavage-induced respiratory failure.
    Sison C; Bry K; Sephus J; Hallman M
    Pediatr Pulmonol; 2000 Mar; 29(3):202-9. PubMed ID: 10686041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasonic nebulization for efficient delivery of surfactant in a model of acute lung injury. Impact on gas exchange.
    Schermuly R; Schmehl T; Günther A; Grimminger F; Seeger W; Walmrath D
    Am J Respir Crit Care Med; 1997 Aug; 156(2 Pt 1):445-53. PubMed ID: 9279222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surfactant lung lavage using asymmetric high-frequency jet ventilation followed by conventional ventilation in rabbits with meconium aspiration.
    Mokra D; Calkovska A; Drgova A; Javorka K
    Bratisl Lek Listy; 2005; 106(12):412-5. PubMed ID: 16642667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The roles of drug therapy given via the endotracheal tube to neonates.
    Greenough A; Papalexopoulou N
    Arch Dis Child Fetal Neonatal Ed; 2017 May; 102(3):F277-F281. PubMed ID: 28270430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surfactant lavage treatment in a model of respiratory distress syndrome.
    Cochrane CG; Revak SD
    Chest; 1999 Jul; 116(1 Suppl):85S-86S. PubMed ID: 10424605
    [No Abstract]   [Full Text] [Related]  

  • 18. Aerosolized surfactant in lung-lavaged adult rats: factors influencing the therapeutic response.
    Bahlmann H; Sun B; Nilsson G; Curstedt T; Robertson B
    Acta Anaesthesiol Scand; 2000 May; 44(5):612-22. PubMed ID: 10786751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aerosolized surfactant therapy for endotoxin-induced experimental acute respiratory distress syndrome in rats.
    Tashiro K; Yamada K; Konzaki T; Yamamoto K; Ohmura S; Kobayashi T; Suzuki Y
    Br J Anaesth; 2001 Aug; 87(2):266-71. PubMed ID: 11493500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic lung lavage in the piglet model of meconium aspiration syndrome.
    Dargaville PA; Mills JF; Headley BM; Chan Y; Coleman L; Loughnan PM; Morley CJ
    Am J Respir Crit Care Med; 2003 Aug; 168(4):456-63. PubMed ID: 12714351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.